Heeschen, C.

biomarker patient level event placental growth factor study value syndrome myeloperoxidase follow-up all-cause mortality model marker non-fatal heart risk strati fication cd 40 ligand infarction non-fatal mi patient characteristics growth factor study population baseline multimarker protein placebo angina treatment signi mortality hscrp placental pregnancy-associated plasma protein flammatory analyses scd 40l investigator non-st-segment elevation elevation outcome table characteristic ficant chest pain analysis population papp-a predictor article all-cause disease signi ficant predictors interleukin cardiology netherland 4- year follow-up b-type natriuretic peptide result high-sensitivity c-reactive protein study investigators variable incidence trial future circulation fication biomarker levels prognostic value multimarker model ejection fraction hamm cw plasma troponin-t 1.6 endpoint heart.bmj.com c-reactive downloaded strati